Host and Moderator:
Eric Ahlstrom, Senior Manager Engineering Projects Amgen
Representing ISPE: Paul Crissman, Biotechnical Solutions
Presentations and Panel Discussion
* Welcome Address
* “Why Lean Design”
* “What Owners Want in a Flexible Manufacturing Facility?”
* Design Case Studies
* “Flexible Facilities of the Future”
* “The Future of Biomanufacturing”
The theme for the evening is how the shift in manufacturing philosophies requires a lean approach to deliver more flexible facilities to supply new demands. These flexible facilities must be designed to reduce CAPEX AND COGMS and be delivered quickly. The speakers will address from their own perspectives the direction the biopharma construction and equipment industry is going and the opportunities for owners and suppliers to participate in this changing environment.
About the Speakers:
Emilio Rivera is Vice President of Engineering and oversees Facilities Operations, Corporate Engineering, Capital Projects, and Global Real Estate. He is leading key Operational Excellence initiatives focused on innovative designs for our next generation facilities as well as helping Amgen’s Global expansion into emerging markets.
Emilio earned a Bachelor’s degree in Chemical Engineering from the University of Puerto Rico, Mayagüez. He joined Amgen in 1996 as Manager, Engineering. Since then he has assumed roles of increasing responsibility in Engineering and Manufacturing. Prior to his current role, Emilio was Vice President and Site Leader for Amgen’s largest manufacturing site located in Puerto Rico. During his tenure in Puerto Rico the site grew significantly in size and complexity ensuring that our patients receive the highest quality products.
Eric Ahlstrom is Senior Manager Engineering Projects at Amgen. During his tenure with Amgen he has delivered projects throughout the Americas and Asia. He currently leads implementation of Lean Project Delivery with several projects currently underway and more planned. Prior to his 20+ year career in project management, Eric led Lean transformation in manufacturing. Mr. Ahlstrom has a degree in Industrial Engineering and a MBA.
Carrier Li is Director in Global Asset Planning supporting Manufacturing Asset Planning at Amgen. He has 28 years of experience in the biopharmaceutical industry. Prior to Amgen, Carrier was Project Design Manager in Merck Manufacturing Division leading Front-End Planning activities in Engineering and Capital Projects across multiple global manufacturing sites. He is Chemical Engineer by training.
Maik W. Jornitz, Chief Operating Officer of G-CON, LLC is a distinguished technical expert with close to 30 years of experience in bioprocesses, especially sterilizing grade filtration and single-use technologies, including regulatory requirements, integrity testing, systems design, and optimization. Jornitz has published multiple books, book chapters and over 100 scientific papers. He is a member of the PDA Science Advisory Board and Audit Committee, as well as an advisory board member of Artemes Technologies, Biotechnology Industry Council and multiple scientific publications. He received his M.Eng. in Bioengineering at the University of Applied Sciences in Hamburg, Germany and accomplished the PED program at IMD Business School in Lausanne, Switzerland.
Parrish Galliher is Chief Technology Officer for Xcellerex, a GE Healthcare Life Sciences Company. Mr. Galliher is the recipient of Bioprocess International’s 2012 “Thought Leader of the Decade” award and is committed to the potential of biotechnology to transform human health. As Founder, President and CEO of Xcellerex he led the creation of the high throughput robotic PDMax™ optimization technology, single use XDR™ bioreactor, XDM™ mixing systems and the turnkey single use modular FlexFactory® biomanufacturing platform. He is also co-inventor on numerous patents in the field of advanced high efficiency biomanufacturing. Mr. Galliher earned his BA in Biology at Boston University and earned his MS degree in Biochemical Engineering at MIT.